| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.09B | +15.5% |
| Cost of Revenue | $5.76B | +17.3% |
| Gross Profit | $1.33B | +8.5% |
| R&D Expense | $149.4M | -10.0% |
| SG&A Expense | $283.4M | -4.3% |
| Operating Income | $897.2M | +17.5% |
| Interest Expense | $58.6M | +13.7% |
| Pre-tax Income | $856.9M | +19.8% |
| Income Tax | $89.9M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $959.1M | +16.0% |
| Short-term Investments | $282.0M | +12.1% |
| Accounts Receivable | $1.37B | +8.5% |
| Inventory | $629.6M | +29.8% |
| Current Assets | $3.30B | +15.6% |
| Total Assets | $6.82B | +13.0% |
| Current Liabilities | $1.66B | -1.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.10B | -2.0% |
| Capital Expenditures | $908.3M | +16.5% |
| Investing Cash Flow | -$1.01B | -6.7% |
| Financing Cash Flow | $55.6M | +284.7% |
| Free Cash Flow | $190.5M | -44.2% |
| +29.4% |
| Net Income | $765.8M | +19.1% |
| EPS (Basic) | $3.13 | +18.6% |
| EPS (Diluted) | $3.11 | +18.7% |
| Long-term Debt |
| $1.09B |
| -5.1% |
| Total Liabilities | $3.12B | +1.8% |
| Stockholders' Equity | $3.67B | +24.7% |